These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31296183)

  • 1. Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.
    Graham-Brown MP; Singh A; Wormleighton J; Brunskill NJ; McCann GP; Barratt J; Burton JO; Xu G
    BMC Nephrol; 2019 Jul; 20(1):256. PubMed ID: 31296183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
    Guan J; Wang M; Zhao M; Ni W; Zhang M
    BMC Nephrol; 2023 Mar; 24(1):60. PubMed ID: 36941570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
    Liu B; Zhao L; Yang Q; Zha D; Si X
    Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of nephrotic IgA nephropathy according to the Oxford classification.
    Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
    Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C; Wang AY; Li G; Wang L
    BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).
    Schimpf JI; Klein T; Fitzner C; Eitner F; Porubsky S; Hilgers RD; Floege J; Groene HJ; Rauen T
    BMC Nephrol; 2018 Nov; 19(1):328. PubMed ID: 30453889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasonography for assessment of tubular atrophy/interstitial fibrosis in immunoglobulin A nephropathy: a preliminary clinical study.
    Yang W; Mou S; Xu Y; Du J; Xu L; Li F; Li H
    Abdom Radiol (NY); 2018 Jun; 43(6):1423-1431. PubMed ID: 29110052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy.
    Hwang JH; Lee JP; Kim CT; Yang SH; Kim JH; An JN; Moon KC; Lee H; Oh YK; Joo KW; Kim DK; Kim YS; Lim CS
    Am J Nephrol; 2016; 44(6):481-492. PubMed ID: 27802442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.
    Mariani LH; Martini S; Barisoni L; Canetta PA; Troost JP; Hodgin JB; Palmer M; Rosenberg AZ; Lemley KV; Chien HP; Zee J; Smith A; Appel GB; Trachtman H; Hewitt SM; Kretzler M; Bagnasco SM
    Nephrol Dial Transplant; 2018 Feb; 33(2):310-318. PubMed ID: 28339906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusional kurtosis imaging in assessing renal function and pathology of IgA nephropathy: a preliminary clinical study.
    Liu Y; Zhang GM; Peng X; Wen Y; Ye W; Zheng K; Li X; Sun H; Chen L
    Clin Radiol; 2018 Sep; 73(9):818-826. PubMed ID: 29929904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.